IRVINE, Calif., Jan. 12 /PRNewswire/ -- Advanced Sterilization Products (ASP) is pleased to announce that its STERRAD(R) CYCLESURE(R) Biological Indicator readout time has significantly improved from a 48 hour incubation time to only 24 hours. Now, STERRAD(R) System customers can safely record biological indicator results in 50% less time, speeding up instrument throughput in the sterilization department. The product name is also changing to STERRAD(R) CYCLESURE(R) 24 Biological Indicator to reflect this time-saving improvement.
ASP successfully re-engineered the product after receiving feedback from customers requesting a faster incubation period. A faster incubation period keeps sterilization departments moving efficiently as well as limiting the need to purchase duplicate instrument inventories, which is frequently required when waiting for the results of a 48 hour or more biological indicator readout.
"ASP has been providing healthcare organizations with STERRAD(R) System technology and supplies for almost two decades," says Karen Borg, Worldwide Vice President of Marketing for ASP. "We are committed to continuous product innovation and are passionate about designing and marketing infection prevention solutions like the STERRAD(R) CYCLESURE(R) 24 Biological Indicator that not only meet our customers' needs, but often exceed them."
The STERRAD(R) CYCLESURE(R) 24 Biological Indicator can be used with all of ASP's market-leading, low-temperature hydrogen peroxide gas plasma STERRAD(R) Systems: the STERRAD(R) 100NX(TM) System, STERRAD(R) NX(TM) System, STERRAD(R) 100S System, STERRAD(R) 200 System, as well as the STERRAD(R) 50 System. The STERRAD(R) CYCLESURE(R) 24 Biological Indicator is only validated for use in STERRAD(R) Systems.
For information about STERRAD(R) System products, ASP or ASP's line of infection prevention solutions, visit www.sterrad.com or call 1-888-STERRAD.
Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health and safety for those who matter most. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives.
For Information Contact: Scott Shadiow Katie Sweet Dorland Global Public Relations ASP 415-262-5206 (office) 949-789-3945 (office) email@example.com firstname.lastname@example.org
|SOURCE Advanced Sterilization Products|
Copyright©2009 PR Newswire.
All rights reserved